SCHEMBL708530

SCHEMBL708530

[CH]=CC=CC=C[CH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1542040 1.00
SCHEMBL1541796 1.00
SCHEMBL1542037 1.00
SCHEMBL187825 0.84
SCHEMBL187824 0.84
SCHEMBL1542069 0.78
SCHEMBL1677666 0.78
SCHEMBL3500074 0.78
SCHEMBL187821 0.73
SCHEMBL187820 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0611772-A2 Catalyst component for use in the polymerization of alpha-olefins and process for producing alpha-olefin polymers using the same MITSUBISHI CHEMICAL CORPORATION (JP) 1994-08-24 EP claimed
US-11744830-B2 Ameliorative agent for cytokine release syndrome and so on TORII PHARMACEUTICAL CO., LTD. (JP) 2023-09-05 US disclosed
US-20210128550-A1 AMELIORATIVE AGENT FOR CYTOKINE RELEASE SYNDROME AND SO ON TORII PHARMACEUTICAL CO., LTD. (JP) 2021-05-06 US disclosed
EP-3782625-A1 AGENT FOR IMPROVING CYTOKINE RELEASE SYNDROME, ETC TORII PHARMACEUTICAL CO., LTD. (JP) 2021-02-24 EP disclosed
CN-112105362-A Ameliorating agent for cytokine release syndrome and the like 鸟居药品株式会社 2020-12-18 CN disclosed
EP-3048098-A1 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS AbbVie Bahamas Limited (BS) 2016-07-27 EP disclosed
EP-1685119-B1 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS ABBVIE BAHAMAS LTD (BS) 2016-03-09 EP disclosed
US-9045444-B2 Apoptosis promoters ABBVIE INC. (US) 2015-06-02 US disclosed
US-20140187531-A1 APOPTOSIS PROMOTERS ABBVIE INC. (US) 2014-07-03 US disclosed
EP-2308812-B1 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS ABBVIE BAHAMAS LTD (BS) 2014-02-26 EP disclosed
US-5489662-A Process for the preparation of organosilicon polymer TOSHIBA SILICONE CO., LTD. (JP) 1996-02-06 US disclosed
US-5488149-A SQUALENE SYNTHASE INHIBITORS AS ANTICHOLESTEROL OR ANTILIPEMIC AGENTS BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-01-30 US disclosed
EP-0641820-A1 Process for the preparation of organosilicon polymer TOSHIBA SILICONE CO., LTD. (JP) 1995-03-08 EP disclosed
EP-0640609-A1 Fused phenol derivatives having inhibitory activity on TXA2 synthetase, and 5-lipoxygenase and scavenging activity on oxygen species ONO PHARMACEUTICAL CO., LTD. (JP) 1995-03-01 EP disclosed
EP-0611749-A1 Substituted amic acid derivatives useful for treatment of arteriosclerosis BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-08-24 EP disclosed
EP-0611772-A2 Catalyst component for use in the polymerization of alpha-olefins and process for producing alpha-olefin polymers using the same MITSUBISHI CHEMICAL CORPORATION (JP) 1994-08-24 EP disclosed
EP-0570594-A1 HYDROXAMIC ACID DERIVATIVE BASED ON AROMATIC SULFONAMIDE SHIONOGI & CO., LTD. (JP) 1993-11-24 EP disclosed
EP-0348203-B1 PHENOLIC THIOETHERS, THEIR PRODUCTION AND USE SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI &amp; CO. LTD. (JP) 1993-02-24 EP disclosed
US-5084214-A Compounds for the treatment of artheriosclerosis SHIONOGI & CO., LTD. (JP) 1992-01-28 US disclosed
EP-0348203-A1 Phenolic thioethers, their production and use SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI &amp; CO. LTD. (JP) 1989-12-27 EP disclosed